Risk of Intraoperative Hypotension with Loop Diuretics: A Randomized Controlled Trial

被引:21
作者
Khan, Nadia A. [1 ]
Campbell, Norman R. [2 ,3 ]
Frost, Shaun D. [6 ,7 ]
Gilbert, Ken [8 ]
Michota, Frank A. [9 ]
Usmani, Ali [9 ]
Seal, Doug [4 ]
Ghali, William A. [2 ,3 ,5 ]
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada
[4] Univ Calgary, Dept Anesthesia, Calgary, AB, Canada
[5] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[6] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[7] Cogent Healthcare, Minneapolis, MN USA
[8] Univ Western Ontario, Dept Med, London, ON, Canada
[9] Cleveland Clin, Inst Med, Dept Hosp Med, Cleveland, OH 44106 USA
基金
加拿大健康研究院;
关键词
Furosemide; Intraoperative hypotension; Perioperative; Surgery; NONCARDIAC SURGERY; MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; DRUG-THERAPY; FUROSEMIDE; PREDICTORS; MORTALITY; PATIENT;
D O I
10.1016/j.amjmed.2010.07.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: There is growing concern regarding the safety of blood pressure-lowering medications administered during the perioperative period. Whether loop diuretics also induce intraoperative hypotension is uncertain. Our objective was to compare the effects of continuing or withholding furosemide on the day of noncardiac elective surgery on intraoperative hypotension among chronic users of furosemide. METHODS: A double blind, randomized, placebo controlled trial was conducted at 3 North American university centers between September 2000 and December 2006. Participants were randomly assigned in a 1: 1 ratio to receive either furosemide or placebo on the day of surgery. The primary outcome was risk of developing intraoperative hypotension. A priori secondary outcomes included risk of heart failure; composite cardiovascular event (myocardial infarction, arrhythmia, stroke or transient ischemic attack, or death); and change in renal function and electrolytes. RESULTS: Of the 212 patients enrolled, 193 patients underwent surgery. There was no significant difference in risk of developing intraoperative hypotension between the furosemide (49%) and placebo (51.9%) groups (relative risk [RR], 0.95; 95% confidence interval [CI], 0.72-1.24; P = .78). The intraoperative administration of vasopressors and fluids were similar between both groups. The risk of developing postoperative cardiovascular events was not significantly different between those randomized to furosemide (4.8%) or placebo (2.8%) (RR, 1.73; 95% CI, 0.42-7.06; P = .49). There was no significant difference in renal function or electrolytes between the 2 groups. CONCLUSION: Among elective, noncardiac surgeries in patients chronically treated with furosemide, the administration of furosemide on the day of surgery did not significantly increase the risk for intraoperative hypotension. (C) 2010 Elsevier Inc. All rights reserved. The American Journal of Medicine (2010) 123, 1059.e1-1059.e8
引用
收藏
页码:1059.e1 / 1059.e8
页数:8
相关论文
共 26 条
  • [1] Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Hoppe, U
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    de Werf, FV
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (18) : 1502 - 1513
  • [2] Subgroup analysis and other (mis)uses of baseline data in clinical trials
    Assmann, SF
    Pocock, SJ
    Enos, LE
    Kasten, LE
    [J]. LANCET, 2000, 355 (9209) : 1064 - 1069
  • [3] Bertrand M, 2001, ANESTH ANALG, V92, P26
  • [4] Incidence of intraoperative hypotension as a function of the chosen definition - Literature definitions applied to a retrospective cohort using automated data collection
    Bijker, Jilles B.
    van Klei, Wilton A.
    Kappen, Teus H.
    van Wolfswinkel, Leo
    Moons, Karel G. M.
    Kalkman, Cor J.
    [J]. ANESTHESIOLOGY, 2007, 107 (02) : 213 - 220
  • [5] Bugar JM, 2002, CLIN INVEST MED, V25, P11
  • [6] Fluctuations in blood lipid levels during furosemide therapy - A randomized, double-blind, placebo-controlled crossover study
    Campbell, N
    Brant, R
    Stalts, H
    Stone, J
    Mahallati, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (13) : 1461 - 1463
  • [7] PREOPERATIVE CHARACTERISTICS PREDICTING INTRAOPERATIVE HYPOTENSION AND HYPERTENSION AMONG HYPERTENSIVES AND DIABETICS UNDERGOING NONCARDIAC SURGERY
    CHARLSON, ME
    MACKENZIE, CR
    GOLD, JP
    ALES, KL
    TOPKINS, M
    SHIRES, GT
    [J]. ANNALS OF SURGERY, 1990, 212 (01) : 66 - 81
  • [8] Effects of extended-release metoprolol succinate inpatients undergoing non-cardiac surgery (POISE trial):: a randomised controlled trial
    Devereaux, P. J.
    Yang, Homer
    Yusuf, Salim
    Guyatt, Gordon
    Leslie, Kate
    Villar, Juan Carlos
    Xavier, Denis
    Chrolavicius, Susan
    Greenspan, Launi
    Pogue, Janice
    Pais, Prem
    Liu, Lisheng
    Xu, Shouchun
    Malaga, German
    Avezum, Alvaro
    Chan, Matthew
    Montori, Victor M.
    Jacka, Mike
    Choi, Peter
    [J]. LANCET, 2008, 371 (9627) : 1839 - 1847
  • [9] Devereaux PJ, 2000, CLIN INVEST MED, V23, P116
  • [10] Fawaz A, 2006, CURR OPIN NEPHROL HY, V15, P643